Conning Inc. Has $33.96 Million Holdings in CME Group Inc. $CME

Conning Inc. lessened its holdings in CME Group Inc. (NASDAQ:CME) by 1.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 124,360 shares of the financial services provider’s stock after selling 2,148 shares during the period. CME Group accounts for 1.1% of Conning Inc.’s portfolio, making the stock its 21st biggest position. Conning Inc.’s holdings in CME Group were worth $33,960,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the business. Truist Financial Corp raised its holdings in CME Group by 8.9% during the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after acquiring an additional 5,773 shares in the last quarter. Elevate Capital Advisors LLC grew its stake in CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares in the last quarter. Ashton Thomas Private Wealth LLC grew its stake in CME Group by 78.8% in the third quarter. Ashton Thomas Private Wealth LLC now owns 13,281 shares of the financial services provider’s stock valued at $3,588,000 after purchasing an additional 5,855 shares in the last quarter. SG Americas Securities LLC increased its position in shares of CME Group by 345.2% during the 4th quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock worth $64,965,000 after purchasing an additional 184,459 shares during the last quarter. Finally, Dover Advisors LLC increased its position in shares of CME Group by 95.5% during the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock worth $1,512,000 after purchasing an additional 2,734 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the transaction, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 7,791 shares of company stock worth $2,489,421 over the last ninety days. Insiders own 0.30% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, expanding its regulated crypto offerings and potentially driving additional trading activity. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: The new futures product is CME’s first market-cap weighted contract, which could broaden participation from both institutional and active retail traders. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Interactive Brokers also said it will integrate CME Group event contracts into a unified prediction-market platform, which may improve distribution and accessibility for CME-linked products. Interactive Brokers Rolls Out Centralized Prediction Market Trading Hub with Kalshi Partnership
• Neutral Sentiment: CME Group also released preliminary annual meeting results, including board elections, but the update appears routine and is unlikely to materially affect the stock. CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Recent analyst commentary remains moderately constructive, but does not appear to be the main driver of the move. Do Wall Street Analysts Like CME Group Stock?

CME Group Stock Performance

CME opened at $297.70 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16. The business has a 50 day moving average of $298.49 and a 200-day moving average of $287.99. The stock has a market cap of $107.87 billion, a price-to-earnings ratio of 25.40, a PEG ratio of 3.59 and a beta of 0.23.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the firm earned $2.80 EPS. The firm’s revenue was up 14.5% compared to the same quarter last year. On average, equities research analysts expect that CME Group Inc. will post 12.26 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CME shares. JPMorgan Chase & Co. increased their price objective on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. Royal Bank Of Canada boosted their target price on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Raymond James Financial upped their price target on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th. Finally, Rothschild & Co Redburn decreased their price objective on shares of CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $305.29.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.